01/06/2025
6:40 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025
6:40 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
4:00 PM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024
6:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
11:13 AM | CytoMed Therapeutics (Subject)
mDR Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
6:44 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024
6:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
6:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
12:43 PM | CytoMed Therapeutics (Filer)
| Form 6-K/A | |
06/20/2024
12:50 PM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
10:12 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
5:10 AM | Choo Chee Kong (Filed by)
CytoMed Therapeutics (Subject)
| Form SC 13G/A | |
04/25/2024
2:31 PM | CytoMed Therapeutics (Filer)
| Form 6-K/A | |
04/24/2024
3:14 PM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
4:22 PM | CytoMed Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/18/2024
5:01 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/04/2024
5:15 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
